767
Views
0
CrossRef citations to date
0
Altmetric
Letters To The Editor

Comments on European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications

, &
Pages 703-704 | Accepted 24 Mar 2005, Published online: 11 Apr 2005

Authors' reply

Adam Jacobsa and Elizabeth Wagerb

dDirector, Dianthus Medical Ltd, London, UK. email: [email protected]

ePublications consultant, Sideview, Princes Risborough, UK

References

  • Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21: 317–21
  • Hamilton CW, Royer MG. AMWA Position Statement on the Contributions of Medical Writers to Scientific Publications. AMWA Journal 2003;18:13–5
  • Food and Drug Administration. Regulation of drug-company-sponsored activities in scientific or educational contexts (draft proposed policy, October 8, 1991). Division of Drug Marketing, Advertising, and Communications (HFD-240), Rockville, MD
  • Food and Drug Administration. Guidance for industry: Industry-supported scientific and educational activities published by FDA. Federal Register 1997;62:64073–100
  • International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. 2003. Available from: www.icmje.org/index.html [Accessed 23 April 2004]
  • International Conference on Harmonisation, Guidance for Industry, E6 Good Clinical Practice: Consolidated Guidance, April 1996, http://www.ifpma.org/pdfifpma/e6.pdf
  • Pharmaceutical Research and Manufacturers of America (PhRMA). Principles on conduct of clinical trials and communication of clinical trial results. 2004:1–54. Available from: www.phrma.org/publications/publications/2004–06–30.1035.pdf [Accessed 28 February 2004]
  • Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin 2003;19:149–54
  • Brennan TA. Buying editorials. N Engl J Med 1994;331:673–5; discussion 676
  • Foote M. Review of current authorship guidelines and the controversy regarding publication of clinical trial data. Biotech Ann Rev 2003;9:303–13
  • Foote M. Guidelines and policies for medical writers. DIA Forum 2004;40:36–9
  • Griffin J. Clinical trial data: Ownership, access, and publication. Clin Res 2002;2:12–2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.